New Zealand researchers say the way methotrexate currently is used to treat rheumatoid arthritis (RA) is not fast enough to control the onset of the joint damage caused by the disease. Scientists at the University of Otago Christchurch monitored the active forms of methotrexate in the blood cells of RA patients who were starting and stopping treatment with the drug. They found that it apparently takes much longer for methotrexate to reach steady blood levels than was previous thought....
Read moreWhen you think of rheumatoid arthritis, you might picture swollen joints, stiffness, pain, deformity, and a lifetime of medications and... Read more »
If you haven't heard about it already, there has been a lot of discussion in the media recently about a shortage of Methotrexate... Read more »
“Oh, crap. No!!” “Wait, this can’t be happening.” “Well, darn.” Do you ever find yourself saying such phrases in your... Read more »
While there is no cure for rheumatoid arthritis, it appears that physicians can stop the progression to rheumatoid arthritis in those... Read more »
I had my six-month check-up with my rheumatologist recently. I have been doing better in some respects, but not in others, and I didn't... Read more »
Drugmaker Novartis is reporting that its generic unit Sandoz has voluntarily recalled 24 lots of methotrexate injection due to the presence of small... Read more »
Scientists say long-term use of methotrexate--even up to a year--does not reduce relapse rates in children who have juvenile idiopathic arthritis. Read more »
This is a study to determine the safety and effectiveness of golimumab, alone or in combination with methotrexate (Trexall, Rheumatrex), compared to... Read more »